Скачать или смотреть Two doses of all EU vaccines protect against Delta variant, EMA says

EU approved COVID-19 vaccines protect against Delta variant - EMA regular press briefing on COVID 19. https://eudebates.tv/ Europe's drug regulator said on Thursday the COVID-19 vaccines approved in the European Union offered protection against all coronavirus variants, including Delta, but called for active monitoring by vaccine manufacturers to stay alert.

#eudebates #Covid_19 #Corona #COVD19 #Health #COVID #vaccine

"There have been a number of variants over the last months and we expect more," said Marco Cavaleri, European Medicines Agency's (EMA) head of vaccine strategy, during a press briefing.

People who have been fully vaccinated with one of the vaccines authorised in the EU seem to be well-protected against the delta coronavirus variant, said the European Medicines Agency (EMA) based on the latest scientific data.
ttps://www.eudebates.tv/debates/eu-policies/health-eu-policies/ursula-von-der-leyen-admits-to-failings-in-vaccine-eu-plan/
In its latest update on the coronavirus vaccines on Thursday, the EMA gave “reassuring news” about the efficacy of the vaccines against the delta variant of the virus.

“We are aware of the concern about the rapid spread of the delta variant and other variants,” said Marco Cavaleri of the EMA. “At the moment, it seems that the four vaccines approved in the EU protect against all virus strains circulating in Europe, including the delta variant.”

New data from field studies show that two doses of vaccines protect against the delta variant, according to him. “Data from lab studies also show that the antibodies of the approved can neutralise the delta variant.”

Additionally, the EMA considers it “too early” to give a definitive recommendation on the use of two different coronavirus vaccines for the two necessary doses, but added that preliminary data show that it is both effective and safe.

Several EU countries, such as France, are already mixing vaccines, by giving people the first dose of AstraZeneca’s vaccine and a second of Pfizer, for example.
ttps://www.eudebates.tv/debates/eu-policies/health-eu-policies/ursula-von-der-leyen-admits-to-failings-in-vaccine-eu-plan/
Belgium is currently not doing this: anyone who received their first shot with the AstraZeneca, Pfizer or Moderna vaccine is offered the same vaccine for their second dose. Only the Johnson & Johnson vaccine is available in one dose.

EU-approved COVID-19 vaccines protect against Delta variant, says official

Europe’s drug regulator said on Thursday the COVID-19 vaccines approved in the European Union offered protection against all coronavirus variants, including Delta, but called for active monitoring by vaccine manufacturers to stay alert.

“There have been a number of variants over the last months and we expect more,” said Marco Cavaleri, European Medicines Agency’s (EMA) head of vaccine strategy, during a press briefing.
ttps://www.eudebates.tv/debates/eu-policies/health-eu-policies/ursula-von-der-leyen-admits-to-failings-in-vaccine-eu-plan/
“It’s very important that there is continuous monitoring and a close surveillance of the performance of all the approved vaccines against emerging variants.”

The highly transmissible Delta variant of SARS-CoV-2 was first identified in India and has led to a wave of new infections around the world.

To monitor potential new threats, vaccine makers have exposed the blood of vaccinated people to viruses engineered to have the typical features of the variant of concern to determine if neutralising antibodies quell that virus.

Currently, the European Union has four COVID-19 vaccines authorized: those from Pfizer and BioNTech, AstraZeneca AZN.L and Oxford, Moderna and Johnson & Johnson.

The EMA said it would proceed with evaluating data from CureVac’s coronavirus vaccine after the German biotech firm said late on Wednesday its jab was only 48% effective in a final analysis.

The agency also reiterated that it had not received any application for authorization of Covishield, the version of AstraZeneca’s vaccine made by India’s Serum Institute, adding that it could approve or accept for use only those shots with ongoing applications.

Friction emerged between India and Europe in recent days over the exclusion of Covishield by the European Union vaccine passport programme as one of its accepted vaccines.

https://eudebates.tv/ #eudebates